Type 2 Diabetes News and Research

Latest Type 2 Diabetes News and Research

How your dairy choices could impact your risk of type 2 diabetes, new study shows

A study of Swedish adults finds that high intake of non-fermented milk and cheese increases the risk of type 2 diabetes, while fermented milk, cream, and butter offer protective benefits.

7 Apr 2025

Scientists discover cellular mechanism to protect and repair mitochondria

Damage to the genetic material of mitochondria – the mitochondrial DNA or mtDNA for short – can lead to diseases such as Parkinson's, Alzheimer's, amyotrophic lateral sclerosis (ALS), cardiovascular diseases and type 2 diabetes.

4 Apr 2025

Alarming statistics from IDF reveal nearly 1 in 9 adults are now living with diabetes

Globally, nearly one in nine adults (589 million) are now living with diabetes. Of these, an estimated 252 million are not yet aware they have the condition, placing them at higher risk of serious complications and early death

4 Apr 2025

Over 250 million people worldwide unaware they have diabetes, according to new research from the International Diabetes Federation (IDF)

4 Apr 2025

Smoothies with seeds may improve glycemic control, study shows

Blending whole fruits into smoothies may reduce glycemic spikes compared to eating fruit whole or drinking juice, especially when seeds are included. Researchers urge a re-evaluation of public health guidelines that currently limit smoothie intake.

3 Apr 2025

Gut bacteria may reduce the effectiveness of common medications

A new study, published today in Nature Chemistry by researchers from the University of Pittsburgh and Yale University, shows how common gut bacteria can metabolize certain oral medications that target cellular receptors called GPCRs, potentially rendering these important drugs less effective.

3 Apr 2025

New data on use of EndoZip™ to treat obese patients be presented at leading global medical conferences

Nitinotes, developer of EndoZip™, a fully automated endoscopic suturing system aimed at treating obesity, today announced that clinical research on the EndoZip™ system will be presented at upcoming leading international medical conferences.

3 Apr 2025

Dutch dietary guidelines could dramatically cut chronic disease rates by 2050

Researchers investigate the impact of current Dutch dietary guidelines on non-communicable disease rates.

3 Apr 2025

Weekend exercise can offer the same health benefits as daily workouts

Being physically active for one to two days a week, often called a "weekend warrior," may provide comparable health and life-prolonging benefits as smaller doses of daily physical activity if the physical effort is moderate to vigorous and totals 150 minutes a week in line with recommended guidelines for weekly physical activity, according to new research published today in the Journal of the American Heart Association, an open access, peer-reviewed journal of the American Heart Association.

2 Apr 2025

Football proven to prevent and treat lifestyle diseases

Danish researchers, in collaboration with the Danish Football Association, have released a White Paper that describes football as an effective recipe in the prevention and treatment of lifestyle-related diseases.

2 Apr 2025

Virtual diabetes self-management interventions improve blood sugar levels

Relatively inexpensive and accessible self-management interventions to help people manage Type 2 diabetes have been found to significantly reduce the blood sugar marker used to diagnose and manage the disease.

1 Apr 2025

Rare sugars curb appetite and mimic diabetes drugs in mice

Rare sugars like D-allulose, D-tagatose, and D-sorbose significantly boosted GLP-1 secretion and suppressed food intake in mice. D-allose also reduced food intake through a unique, GLP-1-independent pathway.

1 Apr 2025

NYC and Baltimore scientists awarded grants for cardiovascular and diabetes research

A New York City-based physician scientist who explores ways to improve health by looking at the ways in which cells and molecules impact disease and an epidemiologist from Baltimore who has devoted her career to identifying ways to improve screening, diagnosis and patient care for people with diabetes are the most recent American Heart Association Merit Award recipients.

1 Apr 2025

UVA Health experts highlight a growing array of treatment options for type 2 diabetes

Nearly 40% of patients diagnosed with type 2 diabetes imperil their health by stopping their medication within the first year, UVA Health diabetes experts note in a new paper highlighting a growing array of treatment options.

1 Apr 2025

Novo Nordisk A/S: Rybelsus® (oral semaglutide 14 mg) demonstrates superior reduction in cardiovascular events in the SOUL trial at ACC 2025

Novo Nordisk today presented the full results from the SOUL cardiovascular outcomes trial, demonstrating that Rybelsus® (oral semaglutide) significantly reduced the risk of major adverse cardiovascular events in adults with type 2 diabetes and cardiovascular disease (CVD) and/or chronic kidney disease (CKD).

1 Apr 2025

Tirzepatide improves kidney, cardiovascular function in patients with obesity and HFpEF

The drug tirzepatide improved kidney function and cardiovascular outcomes among patients with obesity and heart failure with preserved ejection fraction (HFpEF) compared with placebo at one year, according to featured clinical research presented at the American College of Cardiology's Annual Scientific Session (ACC.25) and simultaneously published in JACC.

31 Mar 2025

FAME-3 study reveals similar outcomes for CABG and PCI in severe triple-vessel heart disease

In sharp contrast to earlier studies, patients with severe triple-vessel heart disease fared equally well whether they underwent open-heart bypass surgery (CABG) or a less invasive procedure called PCI (percutaneous coronary intervention) at five years of follow-up, according to research presented at the American College of Cardiology's Annual Scientific Session.

31 Mar 2025

New trial shows oral semaglutide reduces cardiovascular events in diabetes patients

Both the injectable and oral forms of semaglutide, a glucagon-like peptide-1 receptor agonist, have gained recent attention for their effectiveness against weight gain, high blood sugar, and even alcohol cravings.

31 Mar 2025

Eating ultra-processed food daily increases depression risk in older adults

Eating four or more servings of ultra-processed food daily increases the risk of depression by 10% in older adults and modestly reduces their mental health-related quality of life.

30 Mar 2025

Semaglutide improves maximal walking distance in people with symptomatic PAD and Type 2 diabetes

Semaglutide, a glucagon-like peptide 1 (GLP-1) agonist, significantly improved maximal walking distance in people with symptomatic peripheral artery disease (PAD) and Type 2 diabetes in the first-of-its kind trial to evaluate the use of a GLP-1 agonist to manage PAD.

29 Mar 2025

Type 2 Diabetes News and Research

Latest Type 2 Diabetes News and Research

How your dairy choices could impact your risk of type 2 diabetes, new study shows

Scientists discover cellular mechanism to protect and repair mitochondria

Alarming statistics from IDF reveal nearly 1 in 9 adults are now living with diabetes

Over 250 million people worldwide unaware they have diabetes, according to new research from the International Diabetes Federation (IDF)

Smoothies with seeds may improve glycemic control, study shows

Gut bacteria may reduce the effectiveness of common medications

New data on use of EndoZip™ to treat obese patients be presented at leading global medical conferences

Dutch dietary guidelines could dramatically cut chronic disease rates by 2050

Weekend exercise can offer the same health benefits as daily workouts

Football proven to prevent and treat lifestyle diseases

Virtual diabetes self-management interventions improve blood sugar levels

Rare sugars curb appetite and mimic diabetes drugs in mice

NYC and Baltimore scientists awarded grants for cardiovascular and diabetes research

UVA Health experts highlight a growing array of treatment options for type 2 diabetes

Novo Nordisk A/S: Rybelsus® (oral semaglutide 14 mg) demonstrates superior reduction in cardiovascular events in the SOUL trial at ACC 2025

Tirzepatide improves kidney, cardiovascular function in patients with obesity and HFpEF

FAME-3 study reveals similar outcomes for CABG and PCI in severe triple-vessel heart disease

New trial shows oral semaglutide reduces cardiovascular events in diabetes patients

Eating ultra-processed food daily increases depression risk in older adults

Semaglutide improves maximal walking distance in people with symptomatic PAD and Type 2 diabetes

A journey through science, software, and innovation: Insights from the Bruker software team

CellVoyant's AI-Powered Vision for the Future of Cell Therapy

Scalable, Smart, and Accessible: The Future of Lab Automation

Type 2 Diabetes News and Research

Latest Type 2 Diabetes News and Research

A journey through science, software, and innovation: Insights from the Bruker software team

CellVoyant's AI-Powered Vision for the Future of Cell Therapy

Scalable, Smart, and Accessible: The Future of Lab Automation

Newsletters you may be interested in